MBOT (Microbot Medical) Cyclically Adjusted FCF per Share: $-2.09 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MBOT Microbot Medical Inc MBOT
29 GF Score
Price $1.72
! 2 Warning Signs
View Full Analysis

What is Microbot Medical Cyclically Adjusted FCF per Share?

Microbot Medical MBOT -1.15% 29 Cyclically Adjusted FCF per Share is $-2.09 as of Mar. 2026. GuruFocus rates MBOT with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Microbot Medical's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.077. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-2.09 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Microbot Medical's average Cyclically Adjusted FCF Growth Rate was -118.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 78.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 66.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 46.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Microbot Medical was 78.30% per year. The lowest was 4.00% per year. And the median was 12.70% per year.

As of today (2026-08-03), Microbot Medical's current stock price is $1.715. Microbot Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-2.09. Microbot Medical's Cyclically Adjusted Price-to-FCF of today is .


Microbot Medical  (NAS:MBOT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Microbot Medical Cyclically Adjusted FCF per Share Related Terms


Microbot Medical Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Microbot Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbot Medical Cyclically Adjusted FCF per Share Chart

Microbot Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -373.69 -245.39 -115.09 -17.41 -2.51

Microbot Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.10 29.31 45.23 -2.51 -2.09

MBOT vs STXS, DXR, KRMD: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Microbot Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbot Medical Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Microbot Medical's Cyclically Adjusted Price-to-FCF falls into.


MBOT
29GF Score
Microbot Medical Inc MBOT
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbot Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Microbot Medical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.077/330.2130*330.2130
=-0.077

Current CPI (Mar. 2026) = 330.2130.

Microbot Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.609 241.018 -0.834
201609 -4.296 241.428 -5.876
201612 -0.011 241.432 -0.015
201703 -0.435 243.801 -0.589
201706 -0.740 244.955 -0.998
201709 -0.566 246.819 -0.757
201712 -0.529 246.524 -0.709
201803 -0.480 249.554 -0.635
201806 -0.504 251.989 -0.660
201809 -0.457 252.439 -0.598
201812 -0.475 251.233 -0.624
201903 -0.666 254.202 -0.865
201906 -0.111 256.143 -0.143
201909 -0.309 256.759 -0.397
201912 -0.440 256.974 -0.565
202003 -0.337 258.115 -0.431
202006 -0.190 257.797 -0.243
202009 -0.239 260.280 -0.303
202012 -0.264 260.474 -0.335
202103 -0.281 264.877 -0.350
202106 -0.324 271.696 -0.394
202109 -0.308 274.310 -0.371
202112 -0.412 278.802 -0.488
202203 -0.425 287.504 -0.488
202206 -0.448 296.311 -0.499
202209 -0.416 296.808 -0.463
202212 -0.319 296.797 -0.355
202303 -0.400 301.836 -0.438
202306 -0.202 305.109 -0.219
202309 -0.141 307.789 -0.151
202312 -0.154 306.746 -0.166
202403 -0.173 312.332 -0.183
202406 -0.132 314.175 -0.139
202409 -0.168 315.301 -0.176
202412 -0.099 315.605 -0.104
202503 -0.093 319.799 -0.096
202506 -0.071 322.561 -0.073
202509 -0.080 324.800 -0.081
202512 -0.056 324.054 -0.057
202603 -0.077 330.213 -0.077

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-2.09 mean?
Microbot Medical (MBOT) has a Cyclically Adjusted FCF per Share of $-2.09 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Microbot Medical and its competitors.
Is Microbot Medical's Cyclically Adjusted FCF per Share too high?
Microbot Medical's current Cyclically Adjusted FCF per Share is $-2.09. Overall, Microbot Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Microbot Medical's Cyclically Adjusted FCF per Share compare to STXS and DXR?
Microbot Medical's Cyclically Adjusted FCF per Share of $-2.09 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Microbot Medical and its competitors. Microbot Medical's current Cyclically Adjusted FCF per Share is $-2.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbot Medical stock overvalued right now?
Microbot Medical (MBOT) has a current Cyclically Adjusted FCF per Share of $-2.09. The current Cyclically Adjusted FCF per Share is $-2.09. Microbot Medical's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Microbot Medical (MBOT), the current Cyclically Adjusted FCF per Share is $-2.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microbot Medical Business Description

Other Exchanges CY9D:Germany
Address 175 Derby Street, Building 27, Hingham, MA, USA, 02043
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
29GF Score

Get the complete analysis for MBOT

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.72
Price